Literature DB >> 22932980

[Extra-articular manifestations of rheumatoid arthritis].

C Baerwald1, C Kneitz, M Bach, M Licht.   

Abstract

Rheumatoid arthritis (RA) represents an autoimmune disease affecting mostly joints, in particular small finger and toe joints. In addition RA can show extra-articular manifestations in many organs. Information on the frequency of extra-articular manifestations (EAMs) in RA varies greatly in different publications from 17.8% to 40.9% and EAMs tend to become higher with increasing duration and severity of the disease. The exact etiology and pathogenesis are still unclear but vasculitic alterations together with deposition of immune complexes can often be found histopathologically in affected organs. It must also be taken into consideration that EAMs can also be a result of the pharmaceutical therapy. The organ findings can vary greatly which is also reflected in the multitude of clinical symptoms. Possible target organs are the blood vessels, kidneys, central nervous system, cardiovascular system, the lungs, eyes, skin, nails as well as blood and the hemopoetic system. The prognosis for RA becomes progressively worse in the presence of EAMs. Regular and continuous control investigations are necessary in order to be able to diagnose EAMs early and to begin therapy. Therapy includes the administration of non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) and especially in advanced stages cyclophosphamide or biologicals. Therapy is still very empirical due to the lack of appropriate studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932980     DOI: 10.1007/s00393-011-0928-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  88 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

3.  Red lunulae in a patient with rheumatoid arthritis.

Authors:  J L Jorizzo; E B Gonzalez; J C Daniels
Journal:  J Am Acad Dermatol       Date:  1983-05       Impact factor: 11.527

Review 4.  FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.

Authors:  Kazuo Kubota; Kimiteru Ito; Miyako Morooka; Ryogo Minamimoto; Yuko Miyata; Hiroyuki Yamashita; Yuko Takahashi; Akio Mimori
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

5.  Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.

Authors:  B-M Nyhäll-Wåhlin; L T H Jacobsson; I F Petersson; C Turesson
Journal:  Ann Rheum Dis       Date:  2005-09-15       Impact factor: 19.103

6.  The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

Authors:  E J Kroot; B A de Jong; M A van Leeuwen; H Swinkels; F H van den Hoogen; M van't Hof; L B van de Putte; M H van Rijswijk; W J van Venrooij; P L van Riel
Journal:  Arthritis Rheum       Date:  2000-08

7.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

Review 8.  Management of extra-articular disease manifestations in rheumatoid arthritis.

Authors:  Carl Turesson; Eric L Matteson
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

Review 9.  [Kidney involvement in rheumatoid arthritis].

Authors:  A Icardi; P Araghi; M Ciabattoni; U Romano; P Lazzarini; G Bianchi
Journal:  Reumatismo       Date:  2003

10.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study.

Authors:  Yasuyuki Kobayashi; Jon T Giles; Masaharu Hirano; Isamu Yokoe; Yasuo Nakajima; Joan M Bathon; Joao A C Lima; Hitomi Kobayashi
Journal:  Arthritis Res Ther       Date:  2010-09-13       Impact factor: 5.156

View more
  1 in total

Review 1.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.